Med School Audio - Medical Knowledge Reimagined & Learning Made Memorable.

Clinical Deep Dives

Health EN ↓ 756 episodes

Clinical Deep Dives is a Medlock Holmes podcast for clinicians and learners who want understanding, not just information. Using classic medical and surgical texts as a guide and the generative power of AI, each episode explores ideas with curiosity and clarity, designed for learning on the move and knowledge that actually sticks. drmanaankarray.substack.com

Be sure to visit the podcast's website and support the creator: drmanaankarray.substack.com

Author

Med School Audio - Medical Knowledge Reimagined & Learning Made Memorable.

Category

Health

Podcast website

drmanaankarray.substack.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Patho 5: Genes and Human Diseases 08.02.2026

This episode explores disease that begins not with injury or obstruction, but with information. Genes provide the instructions that guide cellular structure, protein synthesis, and response to stress. When these instructions are altered, missing, or misread, vulnerability is built into tissues from the very beginning. Genetic disease is therefore not destiny alone, but probability written into bio...

Patho 4: Hemodynamic Disorders, Thromboembolic Disease, and Shock 08.02.2026

This episode examines disease that emerges not from cellular damage alone, but from disrupted movement. Blood must flow, lymph must drain, and pressure must be regulated. When these forces fall out of balance, tissues suffer even if cells themselves are initially intact. Hemodynamic disorders reveal how disease can arise from stagnation, obstruction, and collapse of circulation. The episode begins...

Patho 3: Inflammation and Repair 08.02.2026

This episode explores inflammation not as an error or excess, but as a purposeful biological conversation. When cells are injured or die, they do not fail silently. They release signals that summon blood vessels, immune cells, and molecular mediators to contain damage, eliminate threats, and prepare the ground for repair. Inflammation is therefore not simply a response to disease. It is the body’s...

Patho 2: Cell Injury, Cell Death, and Adaptations 08.02.2026

This episode moves from cellular normality into the moment where disease truly begins. Cells constantly face stress from reduced oxygen, toxins, infection, immune attack, genetic damage, and nutritional imbalance. Survival depends not on avoiding injury, but on responding to it intelligently. Pathology emerges when these responses fail, overshoot, or arrive too late. The episode begins by examinin...

Patho 1: The Cell as a Unit of Health and Disease 08.02.2026

This opening episode lays the intellectual foundation for all of pathology by returning to its smallest but most decisive stage, the cell. Health and disease are not abstract states but consequences of how cells are built, how they communicate, and how they respond to stress. To understand pathology is to understand what happens when cellular order is strained, distorted, or lost. The episode begi...

Pharma 73: Dosing by Design - Turning Numbers into Care 04.02.2026

This final episode reframes dosage regimen design as the pharmacology of intentional calibration . Pharmacokinetic data are not abstractions-they are tools for shaping exposure over time to maximise benefit and minimise harm. We revisit absorption, distribution, clearance, half-life, and steady state to show how loading doses, maintenance dosing, interval selection, and adjustments for organ funct...

Pharma 72: Prescribing with Purpose - Writing, Trust, Adherence 04.02.2026

This episode reframes prescribing as the pharmacology of communication and trust . A drug’s effectiveness depends not only on its mechanism, but on how clearly it is prescribed, understood, and followed. We explore the principles of prescription writing, patient comprehension, adherence, and concordance to show why errors, omissions, and assumptions undermine even perfect pharmacology. The clinica...

Pharma 71: Environmental Toxicology - Exposure, Accumulation, Aftermath 04.02.2026

This episode explores environmental toxicology as the pharmacology of unintended dosing . Unlike therapeutic drugs, toxins enter the body without consent, instruction, or clear timing-through air, water, food, and work. We examine carcinogens and heavy metals to understand dose–response relationships, bioaccumulation, latency, and organ selectivity, and why harm often appears long after exposure h...

Pharma 70: Dermatological Pharmacology - Treating the Barrier That Remembers 04.02.2026

This episode explores dermatological pharmacology as the science of boundary management . The skin is both shield and signal-exposed to the environment yet deeply connected to immune, endocrine, and neural systems. We examine barrier structure, keratinocyte turnover, inflammation, infection, and pigmentation to understand why topical therapy is as much about where and how a drug is delivered as wh...

Pharma 69: Ocular Pharmacology - Precision at the Edge of Perception 04.02.2026

This episode explores ocular pharmacology as the discipline of micro-precision . The eye demands exactness: millimetres matter, barriers are selective, and systemic exposure must be minimised. We examine aqueous humour dynamics, intraocular pressure control, retinal protection, and local anti-inflammatory and anti-infective strategies to understand why ocular drugs are often topical, slow, and unf...

Pharma 68: Hormonal Cancer Therapy - Starving the Signal, Not the Cell 04.02.2026

This episode explores hormonal cancer therapy as the pharmacology of signal withdrawal . Many cancers-particularly of the breast, prostate, and endometrium-are driven less by unchecked division and more by sustained hormonal instruction. We examine how manipulating endocrine signals can slow, stabilise, or even reverse tumour progression without the cytotoxic burden of traditional chemotherapy. Th...

Pharma 67: Targeted Cancer Therapies - Precision, Pathways, and Resistance 04.02.2026

This episode explores pathway-targeted cancer therapies as the pharmacology of precision with consequences . Monoclonal antibodies, small-molecule kinase inhibitors, and pathway disruptors are designed to strike specific molecular drivers of malignancy-often with dramatic early responses. We unpack oncogenic signalling, addiction to pathways, and biomarker-guided selection to explain why these dru...

Pharma 66: Cytotoxic Drugs - When Division Becomes the Weakness 04.02.2026

This episode focuses on cytotoxic chemotherapy as the pharmacology of turning speed against itself . Cytotoxic drugs do not recognise cancer by identity, but by behaviour-targeting cells that divide rapidly, repair poorly, and fail to pause. We explore antimetabolites, alkylating agents, platinum compounds, antitumour antibiotics, and mitotic inhibitors to understand why efficacy and toxicity are...

Pharma 65: Cancer Pharmacotherapy - Treating Growth Without Losing the Host 04.02.2026

This episode introduces cancer pharmacotherapy as the discipline of constrained aggression . Unlike infections, cancer arises from the host’s own cells-meaning therapy must discriminate between malignant growth and essential renewal. We explore the fundamental principles that govern oncology treatment: cell-cycle vulnerability, therapeutic index, combination regimens, resistance, and the logic of...

Pharma 64: Antiretroviral Therapy - Holding the Line Without Cure 04.02.2026

This episode explores HIV pharmacology as the discipline of durable containment . HIV integrates into host DNA, mutates rapidly, and rebounds when pressure slips-making cure elusive but control achievable. We trace the viral life cycle to understand why combination therapy is essential, how high genetic barriers protect efficacy, and why adherence is the cornerstone of success. The episode frames...

Pharma 63: Viral Hepatitis Therapy - Suppressing a Silent Persistence 04.02.2026

This episode focuses on hepatitis B and C as the pharmacology of containment and clearance . Unlike acute lytic infections, hepatitis viruses persist quietly within hepatocytes, driving chronic inflammation, fibrosis, and long-term risk. We explore the distinct therapeutic logics of HBV suppression versus HCV eradication-nucleos(t)ide analogues that restrain replication over years, and direct-acti...

Pharma 62: Antiviral Therapy - Interrupting Replication Without a Wall 04.02.2026

This episode reframes antiviral therapy as the pharmacology of interruption . Viruses lack cell walls, metabolism, and independent machinery; they succeed by hijacking ours. Effective drugs therefore target steps in replication -entry, uncoating, genome synthesis, assembly, and release-while sparing host function as much as possible. We explore nucleos(t)ide analogues, polymerase and protease inhi...

Pharma 61: Antifungal Therapy - Targeting a Near-Neighbour 04.02.2026

This episode explores antifungal agents as the pharmacology of narrow discrimination . Fungi are eukaryotes-biologically closer to us than bacteria-so effective therapy depends on exploiting small but crucial differences in cell membranes, cell walls, and replication machinery. We examine ergosterol synthesis and binding, cell wall β-glucan inhibition, nucleic acid synthesis interference, and emer...

Pharma 60: Mycobacterial Disease - Winning a War of Attrition 03.02.2026

This episode explores tuberculosis, non-tuberculous mycobacterial disease (including MAC), and leprosy as the pharmacology of endurance . Mycobacteria grow slowly, hide within host cells, and possess formidable cell walls-forcing therapy to be prolonged, multi-drug, and meticulously coordinated. We examine cell wall synthesis inhibition, RNA polymerase targeting, energy metabolism disruption, and...

Pharma 59: Protein Synthesis Inhibitors - Silencing the Factory Floor 03.02.2026

This episode explores antibiotics that target bacterial protein synthesis as the pharmacology of industrial disruption . Rather than collapsing structural walls, these agents interfere with ribosomal function-stalling, misreading, or prematurely terminating protein assembly. We examine tetracyclines, macrolides, lincosamides, chloramphenicol, streptogramins, and oxazolidinones to show how subtle i...

Pharma 58: Aminoglycosides - Power with a Narrow Margin 03.02.2026

This episode examines aminoglycosides as the pharmacology of high-impact precision . These drugs deliver fast, concentration-dependent bactericidal action against serious Gram-negative infections, yet their usefulness is constrained by predictable and serious toxicity. We explore ribosomal binding, oxygen-dependent uptake, post-antibiotic effect, and synergy with cell-wall agents to show why amino...

Pharma 57: β-Lactams - Breaking the Wall Without Breaking the System 03.02.2026

This episode explores β-lactam antibiotics as the pharmacology of structural sabotage . By targeting cell wall synthesis-a feature humans do not possess-penicillins, cephalosporins, carbapenems, and related agents achieve extraordinary selective toxicity. We trace peptidoglycan assembly, penicillin-binding proteins, and bacterial autolysis to explain why these drugs are so effective, why resistanc...

Pharma 56: Broad-Spectrum Decisions - Power, Precision, Consequence 03.02.2026

Episode description (with key takeaways) This episode tackles sulfonamides, trimethoprim–sulfamethoxazole, quinolones, and urinary-tract–focused agents as the pharmacology of broad reach . These drugs are versatile, familiar, and effective-precisely why they demand disciplined use. We explore folate pathway inhibition, DNA gyrase/topoisomerase targeting, tissue penetration, and urinary concentrati...

Pharma 55: Helminth Infections - Targeting Giants with Subtlety 03.02.2026

This episode examines antihelminthic therapy as the pharmacology of selective vulnerability . Helminths are biologically sophisticated, multicellular organisms-far closer to us than bacteria-yet they harbour unique neuromuscular and metabolic features that drugs can exploit. We explore mechanisms that paralyse, starve, or dislodge worms, and why cure often depends as much on host immunity and envi...

Pharma 54: Protozoal Infections - One Kingdom, Many Battles 03.02.2026

This episode expands antimicrobial thinking beyond malaria to the diverse world of protozoal infections-amebiasis, giardiasis, trichomoniasis, leishmaniasis, trypanosomiasis, and beyond. The unifying lesson is diversity: protozoa share a kingdom, not a strategy. We explore metabolic vulnerabilities, tissue tropism, intracellular sanctuaries, and host–parasite dynamics to show why drugs that cure o...

Listen to the Clinical Deep Dives podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.